Eleven Biotherapeutics Up Big Over Past Month

Eleven Biotherapeutics Inc EBIO is currently flirting at $ 0.3998 up 0.0086 from the previous close of $0.39. Eleven Bio is trading at a P/B of 0.26, P/C of 0.17, cheaper than industry average, but Debt/Equity of 0.51 is higher than industry average. Over the year, the stock is 95.81 percent down, year to date the stock has fallen 87.01 percent. On a monthly basis, Eleven Bio shares have increased 34.83 percent.